Glucose-Lowering Effect of Insulin Degludec is Independent of Subcutaneous Injection Region

BACKGROUND AND OBJECTIVES: Patients with diabetes mellitus inject insulin in different regions of the body. This study investigated the pharmacokinetic and pharmacodynamic properties of insulin degludec (IDeg), a new-generation once-daily basal insulin with an ultra-long duration of action, after su...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nosek, Leszek, Coester, Hans-Veit, Roepstorff, Carsten, Thomsen, Henrik F., Kristensen, Niels R., Haahr, Hanne, Heise, Tim
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2014
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4143594/
https://ncbi.nlm.nih.gov/pubmed/25124362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-014-0218-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak